ENSC: Ensysce Biosciences, Inc. Common Stock Company Profile & Statistics

About

Ensysce Biosciences is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is involved in developing tamper-proof opioids which prevent both drug abuse and overdoses. Ensysce Biosciences, formerly known as Leisure Acquisition Corp., is based in SAN DIEGO.

Info & Links

CEO

Lynn Kirkpatrick

Headquarters

7946 IVANHOE AVENUE, SUITE 201
LA JOLLA, CA 92037, UNITED STATES

Auditor

Moss Adams LLP

Share holders

Employees

Ensysce Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

4.88M

Enterprise Value

2.09M

Enterprise Value/EBITDA(ttm)

-0.31

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.66

Price to Book(mrq)

0.79

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-179.26%

Profit Margin(ttm)

-371.00%

Return on Equity(ttm)

-292.81%

Return on Invested Capital(ttm)

-299.93%

Return on Assets(ttm)

-158.83%

Income Statement

Revenue(ttm)

6.22M

Revenue Per Share(ttm)

2.63

Gross Profit(ttm)

6.22M

EBITDA(ttm)³

-6.83M

Net Income Available to Common(ttm)

-6.82M

Diluted EPS(ttm)

-27.44

Share Statistics

Beta (5Y Monthly)

0.54

52-Week Change

-73.46%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

2.37M

Dividend Yield

0.00%

Float⁴

1.20M

% Held by Insiders

7.90%

% Held by Institutions

5.63%

Balance Sheet

Total Cash(mrq)

3.05M

Total Cash Per Share(mrq)

1.29

Total Debt(mrq)

257.40K

Total Debt/Equity(mrq)

9.46%

Current Ratio(mrq)

2.50%

Quick Ratio(mrq)

3.24%

Book Value Per Share(mrq)

1.65

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.22

Free Cash Flow(ytd)

-1.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ENSC

Ensysce Biosciences, Inc. Common Stock

Ensysce Biosciences, Inc. Common Stock Profile